Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
Open Access
- 1 July 2019
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 25 (7), 1281-1288
- https://doi.org/10.3201/eid2507.181200
Abstract
Epidemiology and molecular mechanisms of carbapenem-resistant Pseudomonas aeruginosa identified during 4-month Emerging Infections Program pilot surveillance.Keywords
This publication has 21 references indexed in Scilit:
- Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other BacteriaAntimicrobial Agents and Chemotherapy, 2017
- Multidrug- and Carbapenem-ResistantPseudomonas aeruginosain Children, United States, 1999–2012Journal of the Pediatric Infectious Diseases Society, 2016
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014Infection Control & Hospital Epidemiology, 2016
- Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countriesJournal of Antimicrobial Chemotherapy, 2014
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010Infection Control & Hospital Epidemiology, 2013
- Emergence of KPC-Producing Pseudomonas aeruginosa in the United StatesAntimicrobial Agents and Chemotherapy, 2010
- Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 β-LactamasesAntimicrobial Agents and Chemotherapy, 2009
- First Occurrence of a Pseudomonas aeruginosa Isolate in the United States Producing an IMP Metallo-β-Lactamase, IMP-18Antimicrobial Agents and Chemotherapy, 2006
- First Nosocomial Outbreak of Pseudomonas aeruginosa Producing an Integron-Borne Metallo-β-Lactamase (VIM-2) in the United StatesAntimicrobial Agents and Chemotherapy, 2005
- bla VIM-7 , an Evolutionarily Distinct Metallo-β-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United StatesAntimicrobial Agents and Chemotherapy, 2004